Huntington's disease trials in Germany

In Germany 9 Also abroad 51

9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2/3Taking people
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
Where
Berlin, Bochum, Bonn, Lübeck, Muenster, Taufkirchen (Vils), Ulm
Age
25 years and over
People
400 worldwide
Run by
Skyhawk Therapeutics, Inc.
See details and how to joinNCT07378644 · EU 2025-522263-14-00
Phase 3Taking people
Pridopidine Phase 3 Study in Huntington's Disease
Where
Aachen, Bochum, Erlangen, Muenster, Taufkirchen (Vils), Ulm
Age
23 years to 65 years
People
400 worldwide
Run by
Prilenia
See details and how to joinNCT07609108 · EU 2026-526093-16-00
Phase 2Not yet taking people in Germany
A Phase 2, open-label trial to investigate the long-term safety of VO659 administered intrathecally in participants with Huntington’s disease and spinocerebellar ataxia type 1 and 3
Where
Tuebingen
Age
18 years to 64 years
People
60 worldwide
Run by
Vico Therapeutics B.V.
See details and how to join2026-526408-60-00 · EU 2026-526408-60-00
Phase 1Taking people
A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease
Where
Berlin, Bochum, Bonn, Dresden, Münster, Taufkirchen, Ulm
Age
25 years to 70 years
People
66 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT06585449
Phase 3Taking people
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Where
Aachen, Berlin, Bochum, Bonn, Dresden, Duesseldorf, Erlangen, Freiburg im Breisgau, Luebeck, Muenster, Taufkirchen (Vils), Tuebingen, Ulm, Wuerzburg
Age
21 years to 70 years
People
770 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07326709 · EU 2025-522227-99-00
Phase 1/2Taking people
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
Where
Berlin, Bochum, Bonn, Tuebingen
Age
25 years to 60 years
People
68 worldwide
Run by
Vico Therapeutics B. V.
See details and how to joinNCT05822908 · EU 2024-514328-18-00
Phase 4Taking people
Patient- and care-related benefits of amyloid PET imaging (ENABLE)
Where
Berlin, Bonn, Cologne, Dresden, Erlangen, Essen, Freiburg im Breisgau, Goettingen, Greifswald, Hamburg, Leipzig, Magdeburg, Mainz, Mannheim, Marburg, Munich, Rostock, Tuebingen, Ulm
Age
18 years and over
People
1,126
Run by
Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V.
See details and how to join2023-503705-10-00 · EU 2023-503705-10-00
No phaseTaking people
HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
Where
Bochum, Dresden, Erlangen, Münster, Taufkirchen, Ulm
Age
11 years to 75 years
People
2,500 worldwide
Run by
University College, London
See details and how to joinNCT02855476
No phaseTaking people
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Where
Aachen, Berlin, Bochum, Dresden, Erlangen, Freiburg im Breisgau, Kassel, Lübeck, Marburg, Munich, Münster, Taufkirchen, Ulm, Würzburg
Age
18 years and over
People
35,000 worldwide
Run by
CHDI Foundation, Inc.
See details and how to joinNCT01574053